Healthcare Associated Infections II: Preventive Measures
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Factors Affecting the Risk of Infection
Urinary Tract Infection II: Pathophysiology
Transmission-based Precautions I: Contact, Enteric, and Droplets
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 27, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Ana C De Roo1,2, Scott E Regenbogen1,2
1Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan.
Clostridioides difficile infection (CDI) poses significant risks, especially for older adults and those with underlying conditions. Understanding specific bacterial strains and medication impacts is crucial for effective treatment and reducing recurrence.
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: